225 related articles for article (PubMed ID: 32895427)
1. PCOSKB
Sharma M; Barai RS; Kundu I; Bhaye S; Pokar K; Idicula-Thomas S
Sci Rep; 2020 Sep; 10(1):14738. PubMed ID: 32895427
[TBL] [Abstract][Full Text] [Related]
2. PCOSKB: A KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with PolyCystic Ovary Syndrome.
Joseph S; Barai RS; Bhujbalrao R; Idicula-Thomas S
Nucleic Acids Res; 2016 Jan; 44(D1):D1032-5. PubMed ID: 26578565
[TBL] [Abstract][Full Text] [Related]
3. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics identification of microRNAs involved in polycystic ovary syndrome based on microarray data.
Hou Y; Wang Y; Xu S; Qi G; Wu X
Mol Med Rep; 2019 Jul; 20(1):281-291. PubMed ID: 31115532
[TBL] [Abstract][Full Text] [Related]
5. Conceptualization of functional single nucleotide polymorphisms of polycystic ovarian syndrome genes: an in silico approach.
Prabhu BN; Kanchamreddy SH; Sharma AR; Bhat SK; Bhat PV; Kabekkodu SP; Satyamoorthy K; Rai PS
J Endocrinol Invest; 2021 Aug; 44(8):1783-1793. PubMed ID: 33506367
[TBL] [Abstract][Full Text] [Related]
6. Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome.
Shen H; Liang Z; Zheng S; Li X
Int J Mol Med; 2017 Nov; 40(5):1385-1396. PubMed ID: 28949383
[TBL] [Abstract][Full Text] [Related]
7. Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zeng Z; Lin X; Xia T; Liu W; Tian X; Li M
Biomed Res Int; 2020; 2020():1817094. PubMed ID: 33224973
[TBL] [Abstract][Full Text] [Related]
8. Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks.
Zhou W; Zhang T; Lian Y; Zhang W; Yang M; Li Y; Wang L; Yan X
Reprod Biomed Online; 2022 May; 44(5):777-790. PubMed ID: 35337736
[TBL] [Abstract][Full Text] [Related]
9. Increased miR-188-3p in Ovarian Granulosa Cells of Patients with Polycystic Ovary Syndrome.
Dai B; Jiang J
Comput Math Methods Med; 2021; 2021():5587412. PubMed ID: 33953792
[TBL] [Abstract][Full Text] [Related]
10. Characterization of circular RNA expression profiles in cumulus cells from patients with polycystic ovary syndrome.
Che Q; Liu M; Xu J; Liu Y; Cao X; Dong X; Liu S
Fertil Steril; 2019 Jun; 111(6):1243-1251.e1. PubMed ID: 30979425
[TBL] [Abstract][Full Text] [Related]
11. Explore the potential molecular mechanism of polycystic ovarian syndrome by protein-protein interaction network analysis.
Chen Q; Zheng B; Du S; Lin Y
Taiwan J Obstet Gynecol; 2021 Sep; 60(5):807-815. PubMed ID: 34507653
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome.
Liu L; He D; Wang Y; Sheng M
Mol Med Rep; 2020 May; 21(5):2138-2150. PubMed ID: 32323770
[TBL] [Abstract][Full Text] [Related]
13. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome.
Liu Y; Yu J; Li J; Li W; Ma H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):169-175. PubMed ID: 38678611
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome.
Li Y; Tan Y
Comput Math Methods Med; 2021; 2021():9988347. PubMed ID: 34211581
[TBL] [Abstract][Full Text] [Related]
16. Several critical genes and microRNAs associated with the development of polycystic ovary syndrome.
Wang W; Ji J; Li J; Ren Q; Gu J; Zhao Y; Hong D; Guo Q; Tan Y
Ann Endocrinol (Paris); 2020 Feb; 81(1):18-27. PubMed ID: 32127169
[TBL] [Abstract][Full Text] [Related]
17. Identification of Hub Genes and Biomarkers between Hyperandrogen and Normoandrogen Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zhang T; Liu Y; Li X; Hu B
Comb Chem High Throughput Screen; 2023; 26(1):126-134. PubMed ID: 35379124
[TBL] [Abstract][Full Text] [Related]
18. A subpathway-based method of drug reposition for polycystic ovary syndrome.
Liu HY; Liu JQ; Mai ZX; Zeng YT
Reprod Sci; 2015 Apr; 22(4):423-30. PubMed ID: 25015903
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction.
Wei L; Xin C; Wang W; Hao C
Gene; 2018 Jun; 661():85-94. PubMed ID: 29601948
[TBL] [Abstract][Full Text] [Related]
20. Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS.
Xu B; Zhang YW; Tong XH; Liu YS
Mol Cell Endocrinol; 2015 Mar; 404():26-36. PubMed ID: 25622783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
